Avatar
Alarmolive6

0 Following 0 Followers
1
Improved in order to increase DNA vaccine performance, including the useImproved in order to increase DNA vaccine performance, including the use of adjuvant plasmids expressing immunostimulatory molecules, such as costimulatory molecules, signaling proteins, [18] cytokine, and chemokines . In addition, the use of mixed vaccines in prime-boost immunization strategies or in simultaneous delive
1
Improved in order to increase DNA vaccine performance, including the useImproved in order to increase DNA vaccine performance, including the use of adjuvant plasmids expressing immunostimulatory molecules, such as costimulatory molecules, signaling proteins, [18] cytokine, and chemokines . In addition, the use of mixed vaccines in prime-boost immunization strategies or in simultaneous delive
1
Luble/secreted plasmid product may simultaneously gain access to the majorLuble/secreted plasmid product may simultaneously gain access to the major histocompatibility complex (MHC) class II exogenous pathway in phagocytic cells, for the [15] activation of B cells, CD4+ and CD8+ T lymphocytes . Many reports emphasized on the ability of DNA vaccines to induce immune responses against a variet
1
Luble/secreted plasmid product may simultaneously gain access to the majorLuble/secreted plasmid product may simultaneously gain access to the major histocompatibility complex (MHC) class II exogenous pathway in phagocytic cells, for the [15] activation of B cells, CD4+ and CD8+ T lymphocytes . Many reports emphasized on the ability of DNA vaccines to induce immune responses against a variet
1
Require further optimization. In addition to viral vectors, recombinant bacterial carriersRequire further optimization. In addition to viral vectors, recombinant bacterial carriers, derived from lactic acid bacteria, Salmonella and L. monocytogenes strains, have been used extensively as delivery systems being able to stimulate both systemic [29,30] and mucosal immune responses .GENE DELIVERY
1
Require further optimization. In addition to viral vectors, recombinant bacterial carriersRequire further optimization. In addition to viral vectors, recombinant bacterial carriers, derived from lactic acid bacteria, Salmonella and L. monocytogenes strains, have been used extensively as delivery systems being able to stimulate both systemic [29,30] and mucosal immune responses .GENE DELIVERY
1
Require further optimization. In addition to viral vectors, recombinant bacterial carriersRequire further optimization. In addition to viral vectors, recombinant bacterial carriers, derived from lactic acid bacteria, Salmonella and L. monocytogenes strains, have been used extensively as delivery systems being able to stimulate both systemic [29,30] and mucosal immune responses .GENE DELIVERY
1
Improved in order to increase DNA vaccine performance, including the useImproved in order to increase DNA vaccine performance, including the use of adjuvant plasmids expressing immunostimulatory molecules, such as costimulatory molecules, signaling proteins, [18] cytokine, and chemokines . In addition, the use of mixed vaccines in prime-boost immunization strategies or in simultaneous delive